2008 GASTROINTESTINAL CANCERS SYMPOSIUM
Science and Multidisciplinary Management of GI Malignancies

Program Agenda

---

Friday, January 25, 2008

---

Breakfast
7:30 AM – 8:30 AM
Continental Breakfast Provided

Welcome
8:30 AM – 8:45 AM

General Session I: Cancers of the Esophagus and Stomach – Prevention, Screening, and Diagnosis
8:45AM – 10:15AM
Moderator: Prateek Sharma, MD – University of Kansas School of Medicine

Screening/Surveillance of Individuals at Risk for Esophageal Adenocarcinoma –– Does it Matter?
Chin Hur, MD, MPH – Massachusetts General Hospital

The Changing Epidemiologic Landscape of Esophageal and Gastric Cancer
William J. Blot, PhD – Vanderbilt-Ingram Cancer Center, International Epidemiology Foundation

Abstract Presentations

Anti–reflux Therapy for Gastroesophageal Reflux Disease: Impact on Progression of Dysplasia
John G. Hunter, MD – Oregon Health and Science University
Gary W. Falk, MD, MS – Cleveland Clinic

Question and Answer Session

Break
10:15 AM – 10:30 AM

General Session II: Cancers of the Esophagus and Stomach – Translational Research
10:30AM – 12:00PM
Moderator: Josep Tabernero, MD – Vall d'Hebron University Hospital

Gastrointestinal Stromal Tumor: Exploiting Molecular Mechanisms to Improve Patient Care
Robert G. Maki, MD, PhD – Memorial Sloan-Kettering Cancer Center

Molecular Therapies in Esophageal and Gastric Cancer: Are We on Target?
Josep Tabernero , MD – Vall d'Hebron University Hospital

Stem Cells and Their Role in Gastric Cancer
James R. Goldenring, MD, PhD – Vanderbilt-Ingram Cancer Center

Abstract Presentations

General Poster Session A
12:00 PM – 1:00 PM
Box Lunches Provided

Fellows, Residents and Junior Faculty Luncheon
12:00 PM – 1:00 PM

Oral Abstract Presentation A
1:00 PM – 2:00 PM
Moderator: Mitchell C. Posner – University of Chicago Hospital

Break
2:00 PM – 2:15 PM

General Session III: Cancers of the Esophagus and Stomach – Multidisciplinary Treatment
2:15PM – 3:45PM
Moderators : David Ilson, MD – Memorial Sloan-Kettering Cancer Center
                      Laura Dawson, MD – Princess Margaret Hospital

Tailoring Multimodality Treatment for Gastroesophageal Junction Adenocarcinoma
Stephen E. Swisher, MD – M. D. Anderson Cancer Center

Multimodality Therapy for Esophageal Squamous Cell Carcinoma –– Is Surgery a Footnote?
Rebecca Wong, MBChb – Princess Margaret Hospital

Endoscopic Resection Techniques for Esophageal and Gastric Cancer
Irving Waxman, MD – University of Chicago Medical Center
Abstract Presentations

Question and Answer Session

Break
3:45 PM – 4:00 PM

General Session IV: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract – Prevention, Screening, and Diagnosis
4:00PM – 5:30PM
Moderator: Philippe Ruszniewski, MD – Hôpital Beaujon

Identifying High Risk Populations for Hepatocellular Carcinoma: What is the Standard for Screening?
Eugene R. Schiff, MD – University of Miami Miller School of Medicine

Imaging of Primary Hepatic Tumors: Differential Diagnosis and Resectability Criteria
Valérie Vilgrain , MD – Hôpital Beaujon

Question and Answer Session

Controversies in the Diagnosis and Management of Cystic Neoplasms of the Pancreas
Pascal Hammel, MD – Hôpital Beaujon
Keith D. Lillemoe, MD, FACS – Indiana University Melvin and Bren Simon Cancer Center

Question and Answer Session

General Poster Session B
5:30 PM – 6:30 PM
Wine and Cheese Reception

---

Saturday, January 26, 2008

---

Breakfast
7:30 AM – 8:30 AM
Continental Breakfast Provided

Meet the Professor Sessions
7:30 AM – 8:30 AM
Continental Breakfast Provided

Extent and Role of Resection for Esophageal Cancer
Simon Law, MS, MBBChir, MA, FRCS, FCSHK, FHKAM, FACS – The University of Hong Kong

Role of Radiation in Gastric Cancer: Is It Necessary?
Jolie Ringash , MD – Princess Margaret Hospital
Takeshi Sano, MD – National Cancer Center Tokyo

Optimal Integration of Chemotherapy or Radiation Therapy for Localized Pancreatic Cancer: When, Why, and How
Jordan Berlin, MD – Vanderbilt Ingram Cancer Center
Christopher Crane, MD – M. D. Anderson Cancer Center

Optimal Integration of Surgical and Nonsurgical Approaches for Noncolorectal Cancer Liver Metastases
Bryan M. Clary, MD – Duke University Medical Center
Michael C. Garofalo, MD – University of Maryland
Michael J. Wallace, MD – M. D. Anderson Cancer Center

Targeted Therapies for Colon Cancer: What Combinations of Agents Should We Be Using?
Emily K. Bergsland, MD – University of California San Francisco Comprehensive Cancer Center

Break
8:30 AM – 8:45 AM

General Session V: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract – Multidisciplinary Treatment
8:45AM – 10:15AM
Moderator: William Regine, MD – University of Maryland
                    Francesco Izzo, MD – Fondazione G. Pascale – National Cancer Institute of Naples

Current Approaches to the Management of Pancreatic Endocrine Tumors and Gastrointestinal Carcinoids
Matthew Kulke, MD – Dana-Farber Cancer Institute

Who Should Undergo Liver Transplant for Hepatocellular Carcinoma and Cholangiocarcinoma?
David A. Geller, MD, FACS – University of Pittsburgh Starzl Transplantation Institute

Chemoradiation Therapy for Liver Tumors: Asian Perspective
Jinsil Seong, MD, PhD – Yonsei University Medical College

Question and Answer Session

Abstract Presentations

Question and Answer Session

Break
10:15 AM – 10:30 AM

General Session VI: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract – Translational Research
10:30AM – 12:00PM
Moderator : Andrew M. Lowy – University of California San Diego

Novel Targets in Pancreatic Cancer
Craig D. Logsdon, PhD – M. D. Anderson Cancer Center

Vaccines for Pancreatic Cancer
Elizabeth M. Jaffee, MD – The Johns Hopkins University School of Medicine

Predictive Markers for Gemcitabine Sensitivity in Pancreatic Cancer
James Farrell, MD – David Geffen School of Medicine at UCLA

Abstract Presentations

General Poster Session C
12:00 PM – 1:00 PM
Box Lunches Provided

Oral Abstract Presentation B
1:00 PM – 2:00 PM
Moderator : Dan Laheru, MD – Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Break
2:00 PM – 2:15 PM

General Session VII: Cancers of the Colon and Rectum: Prevention, Screening, and Diagnosis
2:15PM – 3:45PM
Moderator : Vincent Yang, MD, PhD – Emory University School of Medicine

Controversies and Advances in Colonoscopic Colorectal Cancer Screening
Randall W. Burt, MD – University of Utah Huntsman Cancer Institute

Chemoprevention: Will it Ever Happen?
Eugene W. Gerner, PhD – Arizona Cancer Center

Diagnosing and Staging Rectal Cancer: Endoscopic Ultrasound vs. Pelvic Magnetic Resonance Imaging
Gina Brown, MD – The Royal Marsden Hospital NHS Trust

Abstract Presentations

Break
3:45 PM – 4:00 PM

General Session VIII: Cancers of the Colon and Rectum: Translational Research
4:00PM – 5:30PM
Moderator : Scott Kuwada, MD – University of Utah Huntsman Cancer Institute

Colorectal Cancer Stem Cells –– Implications for Treatment
Catherine A. O’Brien, BSc, MD, MSc, FRCSC – University Health Network

Circulating Tumor Cells: Are They Predictive Markers?
Neal J. Meropol, MD – Fox Chase Cancer Center

Mechanisms of Resistance to Epidermal Growth Factor Receptor Inhibitors: Is It Time to Start Selecting Patients?
Heinz-Josef Lenz, MD – University of California Norris

Abstract Presentations

Question and Answer Session

General Poster Session D
5:30 PM – 6:30 PM
Wine and Cheese Reception

Meet the Professor Sessions
5:30 PM – 6:30 PM

Role of Radiation in Gastric Cancer: Is It Necessary?
Jolie Ringash , MD – Princess Margaret Hospital
Takeshi Sano, MD – National Cancer Center Tokyo

Optimal Integration of Chemotherapy or Radiation Therapy for Localized Pancreatic Cancer: When, Why, and How
Jordan Berlin, MD – Vanderbilt-Ingram Cancer Center
Christopher Crane, MD – M. D. Anderson Cancer Center

Optimal Integration of Surgical and Non-surgical Approaches for Noncolorectal Cancer Liver Metastases
Bryan M. Clary, MD – Duke University Medical Center
Michael C. Garofalo, MD – University of Maryland
Michael J. Wallace, MD – M. D. Anderson Cancer Center

Targeted Therapies for Colon Cancer: What Combinations of Agents Should We Be Using?
Emily K. Bergsland, MD – University of California San Francisco Comprehensive Cancer Center

When to Refer Patients With Colorectal Cancer for Genetic Testing
Marcia Cruz-Correa, MD, PhD – University of Puerto Rico

---

Sunday, January 27, 2008

---

General Poster Session E
7:00 AM – 8:00 AM
Continental Breakfast Provided

Break
8:00 AM – 8:15 AM

Scott Wadler Keynote Lecture
8:15 AM – 9:00 AM

Introduction
Howard Hochster, MD – New York University School of Medicine

What Will It Take to Diagnose Pancreatic Cancer Early?
Ralph H. Hruban, MD – The Johns Hopkins University School of Medicine

General Session IX: Cancers of the Colon and Rectum: Multidisciplinary Treatment
9:00AM – 10:30AM
Moderator : Christopher Willett, MD – Duke University Medical Center

Abstract Presentation

Integration of Epidermal Growth Factor Receptor Targeting into First Line Therapy: Is it Time?
Eric Van Cutsem, MD – University Hospital of Gasthuisberg, Leuven

Current Management of Anal Cancer
Christopher Willett, MD – Duke University Medical Center

Novel Approaches to the Management of Peritoneal Carcinomatosis
Paul F. Mansfield, MD – M. D. Anderson Cancer Center

Abstract Presentation

Break
10:30 AM – 10:45 AM

Oral Abstract Presentation C
10:45 AM – 12:00 PM
Moderator: Emily K. Bergsland, MD – University of California San Francisco Comprehensive Cancer Center

General Poster Session E (Cont'd)
12:00 PM – 1:00 PM
Box Lunches Provided

General Session X: Cancers of the Colon and Rectum: Controversies
1:00PM – 2:00PM
Moderator : David Linehan, MD – Washington University School of Medicine

No Chemotherapy Before Surgery for Hepatic Metastases
Kenneth Tanabe, MD – Massachusetts General Hospital Cancer Center

Chemotherapy Before Surgery for Hepatic Metastases
John L. Marshall, MD – Lombardi Comprehensive Cancer Center

Question and Answer Discussion and Rebuttal